OTCMKTS:NVZMF

Novozymes A/S Stock Forecast, Price & News

$79.25

-2.10 (-2.58 %)

(As of 08/3/2021 12:00 AM ET)

Add

Compare

Today's Range

$76.96

▼

$79.25

50-Day Range

$70.53

▼

$81.35

52-Week Range

$55.00

▼

$81.35

Volume350 shs

Average Volume1,020 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive NVZMF News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

About Novozymes A/S

Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.

Novozymes A/S (OTCMKTS:NVZMF) Trading Up 2.3%
July 27, 2021 | americanbankingnews.com

AXTA vs. NVZMY: Which Stock Should Value Investors Buy Now?
May 17, 2021 | finance.yahoo.com

CE vs. NVZMY: Which Stock Should Value Investors Buy Now?
April 29, 2021 | finance.yahoo.com

Professional cleaning companies collaborate to evaluate the benefit of probiotics in green cleaning, in response to COVID-19
April 29, 2021 | finance.yahoo.com

Novozymes A/S 2021 Q1 - Results - Earnings Call Presentation
April 29, 2021 | seekingalpha.com

Initiation of stock buyback program
February 8, 2021 | finance.yahoo.com

Novozymes A/S : Novozymes delivers resilient full-year results despite the COVID-19 pandemic and is confident about getting back to growth in 2021
February 5, 2021 | markets.businessinsider.com

Novozymes A/S (NVZMF) CEO Ester Baiget on Q4 2020 Results - Earnings Call Transcript
February 4, 2021 | seekingalpha.com

Change of management
November 23, 2020 | finance.yahoo.com

Novozymes A/S (NVZMF) CEO Ester Baiget on Q3 2020 Results - Earnings Call Transcript
October 23, 2020 | seekingalpha.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NVZMF
Previous Symbol
CUSIPN/A
CIK1131345
Webwww.novozymes.com
Phone(454) 446-0000
Employees6,274
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.75 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Novozymes A/S.

3.7 Community Rank

Outperform Votes
Novozymes A/S has received 41 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Novozymes A/S has received 31 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Novozymes A/S has received 56.94% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Novozymes A/S and other stocks. Vote “Outperform” if you believe NVZMF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NVZMF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Novozymes A/S does not currently pay a dividend.
Dividend Growth
Novozymes A/S does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Novozymes A/S insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Novozymes A/S (OTCMKTS:NVZMF) Frequently Asked Questions

What stocks does MarketBeat like better than Novozymes A/S?

Wall Street analysts have given Novozymes A/S a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Novozymes A/S wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Novozymes A/S's earnings last quarter?

Novozymes A/S (OTCMKTS:NVZMF) issued its earnings results on Wednesday, April, 20th. The biotechnology company reported $0.37 EPS for the quarter, missing analysts' consensus estimates of $2.43 by $2.06.
View Novozymes A/S's earnings history.

How has Novozymes A/S's stock price been impacted by COVID-19?

Novozymes A/S's stock was trading at $45.90 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NVZMF stock has increased by 72.7% and is now trading at $79.25.
View which stocks have been most impacted by COVID-19.

Who are Novozymes A/S's key executives?

Novozymes A/S's management team includes the following people:

Ester Baiget, President & Chief Executive Officer
Graziela Chaluppe dos Santos Malucelli, Chief Operating Officer & Executive VP
Lars Green, Chief Financial Officer & Executive Vice President
Claus Crone Fuglsang, Chief Scientific Officer & Executive VP
Anders Lund, EVP & Head-Consumer Biosolutions

Who are some of Novozymes A/S's key competitors?

Some companies that are related to Novozymes A/S include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS) and Amplia Therapeutics (ATX).
View all of NVZMF's competitors.

What is Novozymes A/S's stock symbol?

Novozymes A/S trades on the OTCMKTS under the ticker symbol "NVZMF."

How do I buy shares of Novozymes A/S?

Shares of NVZMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novozymes A/S's stock price today?

One share of NVZMF stock can currently be purchased for approximately $79.25.

How many employees does Novozymes A/S have?

Novozymes A/S employs 6,274 workers across the globe.

What is Novozymes A/S's official website?

The official website for Novozymes A/S is www.novozymes.com.

Where are Novozymes A/S's headquarters?

Novozymes A/S is headquartered at Krogshoejvej 36, BAGSVAERD, 2880, Denmark.

How can I contact Novozymes A/S?

Novozymes A/S's mailing address is Krogshoejvej 36, BAGSVAERD, 2880, Denmark. The biotechnology company can be reached via phone at (454) 446-0000.

This page was last updated on 8/3/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Novozymes A/S Stock Forecast, Price & News

About Novozymes A/S

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

3.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment